Universidade Federal de São Paulo, Departamento de Medicina, Disciplina de Nefrologia, São Paulo, SP, Brasil.
Universidade Federal de São Paulo, Instituto de Ciência e Tecnologia, São Paulo, SP, Brasil.
J Bras Nefrol. 2021 Oct-Dec;43(4):510-519. doi: 10.1590/2175-8239-JBN-2020-0236.
According to the International Diabetes Federation, the number of people with diabetes mellitus may reach 700 million in 2045. Catecholamines are involved in the regulation of several kidney functions. This study investigates the effects of hyperglycemia on catecholamines' metabolism in kidney tissue from control, diabetic, and insulin-treated diabetic rats, both in vivo and in vitro.
Male Wistar-Hannover rats were randomized into: control, diabetic, and insulin-treated diabetic groups. Diabetes was induced by a single injection of streptozotocin, and diabetic treated group also received insulin. After 60 days, blood and kidney tissue from all groups were collected for catecholamines' quantification and mesangial cells culture.
diabetic rats had lower body weight, hyperglycemia, and increase water intake and diuresis. Additionally, diabetes promoted a sharp decrease in creatinine clearance compared to control group. Regarding the whole kidney extracts, both diabetic groups (treated and non-treated) had significant reduction in norepinephrine concentration. In mesangial cell culture, catecholamines' concentration were lower in the culture medium than in the intracellular compartment for all groups. Norepinephrine, epinephrine, and dopamine medium levels were increased in the diabetic group.
The major finding of the present study was that 8 weeks of diabetes induction altered the kidney catecholaminergic system in a very specific manner, once the production of catecholamines in the excised kidney tissue from diabetic rats was differentially modulated as compared with the production and secretion by cultured mesangial cells.
根据国际糖尿病联合会的数据,到 2045 年,糖尿病患者人数可能达到 7 亿。儿茶酚胺参与了多种肾脏功能的调节。本研究旨在探讨高血糖对正常、糖尿病和胰岛素治疗的糖尿病大鼠肾组织儿茶酚胺代谢的体内和体外影响。
雄性 Wistar-Hanover 大鼠随机分为:正常组、糖尿病组和胰岛素治疗的糖尿病组。糖尿病通过单次链脲佐菌素注射诱导,胰岛素治疗的糖尿病组也接受胰岛素治疗。60 天后,收集所有组的血液和肾脏组织用于儿茶酚胺的定量和系膜细胞培养。
糖尿病大鼠体重减轻、出现高血糖、饮水和排尿量增加。此外,与正常组相比,糖尿病组的肌酐清除率明显下降。对于整个肾脏提取物,未治疗和治疗的糖尿病组的去甲肾上腺素浓度均显著降低。在系膜细胞培养中,所有组的细胞内儿茶酚胺浓度均低于细胞外培养液。糖尿病组的去甲肾上腺素、肾上腺素和多巴胺的细胞外浓度增加。
本研究的主要发现是,8 周的糖尿病诱导以一种非常特殊的方式改变了肾脏儿茶酚胺能系统,因为与培养的系膜细胞的产生和分泌相比,糖尿病大鼠离体肾脏组织儿茶酚胺的产生被不同程度地调节。